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Background: The role of plasma triglycerides (TG) in cardiovascular disease (CVD) is widely debated. Although some studies have demonstrated 
that CVD risk among individuals with similar levels of low-density lipoprotein cholesterol (LDL-C) may be driven by their plasma triglyceride levels, 
the importance of triglycerides requires further clarification.
Methods: The baseline data were collected as a part of the Third National Health and Nutrition Examination Survey (NHANES III), a nationally 
representative sample of non-institutionalized civilians. A cohort of 3,972 adults aged 40 years and older at baseline (1988-1994) was followed 
through December, 2000 for mortality from all causes using the NHANES III Linked Mortality File. Optimal LDL-C and normal TG were defined as 
fasting level <100 mg/dL and <150 mg/dL, respectively. Cox proportional hazard models were used to estimate the hazard ratio (HR) of death for 
the group with optimal LDL-C/abnormal TG (n=188) in comparison with the optimal LDL-C/normal TG group (n=455) after adjusting for age, race-
ethnicity, lipid-lowering medication, and established CVD risk factors.
Results: A total of 170 all-cause and 68 CVD deaths were observed among participant with the optimal LDL-C. Compared to “optimal LDL-C/
normal TG”, “optimal LDL-C/abnormal TG” profile was significantly associated with CVD mortality (adjusted HR, 2.2; 95% CI: 1.3−3.6). However, 
these associations were modified by age and gender. “Optimal LDL-C/abnormal TG” profile was strongly associated with CVD death in adults 40-65 
years (adjusted HR, 2.9; 95% CI: 1.1−7.3) and women (4.6; 95% CI, 2.2−9.7) but not in older adults (65 yrs and older) (adjusted HR, 1.9; 95% CI: 
0.96−3.7) or men (adjusted HR, 1.2: 95% CI: 0.5−2.6). Among women, “optimal LDL-C/ abnormal TG” profile was also a significant independent 
predictor of all-cause mortality (1.9; 95% CI: 1.1−3.3).
Conclusion: In our large nationally representative longitudinal study, “optimal LDL-C/ abnormal TG” lipid profile was significantly associated with 
cardiovascular mortality, particularly in adults 40-65 years and women.
